Latest Interviews
Showing 16–30 of 52 transcripts.
Clear all filters- Milken Institute31 min
A Conversation With Indra Nooyi and Mike Milken
Former PepsiCo CEO Indra Nooyi championed the "Performance with Purpose" strategy to secure generational longevity by aligning financial growth with human, environmental, and workforce sustainability. She countered investor skepticism regarding short-term restructuring charges by restructuring the product portfolio and engaging directly as a global statesman to navigate complex regulatory and implementation challenges. Nooyi further advocated for systemic workforce retention solutions, including mandatory family support systems, while driving regional gender inclusion strategies to leverage the purchasing power of women.
- Milken Institute42 min
A Fireside Chat with Serge Pun Building Myanmar
Serge Pun, Staci Warden, Mike Milken, Mahendra Lama, Minseok Lee, Dickey Yuhuiko, Brad Gordon
Expanding from a private interview to a public forum, the Milken Institute session featured Serge Poon and Mike Milken discussing Myanmar's shifting economic landscape following the removal of US sanctions. Poon detailed his forty-year journey from displacement to rebuilding a private banking empire through strict anti-corruption practices, while outlining a strategy prioritizing long-term infrastructure investment over short-term gains. The dialogue concluded with an optimistic five-year forecast for nation-building, emphasizing regional connectivity and the need for investors to support foundational "trunk" projects despite lingering political risks.
- Milken Institute1h 10m
Lunch Program | This Changes Everything: How Technology Is Revolutionizing Medicine
Margaret Anderson, Mike Milken, Jack Gilbert, Elizabeth Blackburn, Vadim Bachman, Nina Tandon, Juan Enriquez, Mike Cloughton
Based at the Milken Institute, Faster Cures convenes leading scientists like Dr. Elizabeth Blackburn and Juan Enriquez to advocate for a systemic overhaul of biomedical research that addresses the critical gap between 10,000 known diseases and the 500 treatments currently in development. The event highlights transformative breakthroughs in genomics, microbiome manipulation, and synthetic biology, demonstrating how technologies such as nanocytology and living implants are shifting medical paradigms toward early detection and regenerative solutions. By integrating public policy advocacy with these scientific advancements, the organization aims to optimize the research ecosystem and accelerate the delivery of cures for conditions ranging from cancer to neurodegenerative disorders.
- Milken Institute1h 6m
Priorities for the Next U.S. President
Jeff Green, Tillman Fertitta, Ellen Townsher, Frank Luntz, Mike Milken
Four former presidential candidates—Jeff Green, Tillman Fertitta, Ellen Townsher, and Frank Luntz—discussed hypothetical policy outcomes at the final session of the Milken Institute conference, moderated by Wolf Blitzer and Mike Milken. Each panelist detailed specific legislative achievements in their imagined administrations, ranging from Green's $1.2 trillion infrastructure plan and Guaranteed Minimum Income to Fertitta's elimination of corporate deficits and Luntz's failed VA reform efforts. The discussion highlighted divergent approaches to governance, with candidates sharing contrasting results on economic growth, foreign relations, and the practical challenges of implementing bold structural changes.
- Milken Institute59 min
Credit Market Outlook
Michael Milken, Richard Byrne, Scott Minerd, Joseph Naggar, David Warren, James Zelter, Mike Milken, Rich Byrne
The panel examined a complex credit environment characterized by historically high corporate debt levels and constrained bank liquidity, which has created significant arbitrage opportunities in special situations, distressed commercial real estate, and non-bank lending. Industry leaders emphasized that effective capital deployment now demands substantial technological infrastructure and deep sector expertise, leading to a market dynamic where active management consistently outperforms passive strategies. While current conditions favor a "credit alpha" environment with yields ranging from 8% to 16%, experts warn that regulatory pressures and potential recessionary headwinds will likely drive future industry consolidation toward larger, well-capitalized firms.
- Milken Institute14 min
Mike Milken │ Public Health and Prosperity
Historical shifts in medical research funding and technological advancements have reduced genome sequencing costs to approximately $1,000 while driving significant economic growth through improved public health. A modern summit now unites government agencies, pharmaceutical entities, and insurers to address the trillion-dollar burden of lifestyle-related diseases by prioritizing prevention, accelerating translational science, and fostering public-private partnerships. This collective strategy aims to fundamentally transform the treatment of life-threatening conditions through innovations like cancer vaccines and immunology drugs within the next few years.
- Milken Institute1h 26m
Public Health Summit Dinner March 2, 2016
Mike Milken, Tom Frieden, Rob Califf, Fred Upton, Nancy Pelosi, Francis Collins
This event featured key figures including Francis Collins, FDA Commissioner Rob Califf, and CDC Director Tom Frieden discussing critical public health challenges such as the implementation gap between knowledge and action, rising opioid overdose deaths, and the threat of a post-antibiotic era. The proceedings highlighted specific policy responses ranging from Mexico's successful food taxes and "health stops" to the U.S. House passing the 21st Century Cures Act and funding the Brain Initiative, alongside clinical breakthroughs in treating depression and heart failure. To address these systemic issues, officials urged for robust funding, the adoption of global "find, stop, prevent" strategies, and a massive volunteer effort for the Precision Medicine Initiative to accelerate biomedical discovery.
- Milken Institute1h 15m
Asia Summit 2015 - Global Capital Markets: Taking Stock of Recent Developments
Martinson, David Bonderman, Josh Harris, Michael Kim, Mike Milken
At the concluding panel of the Milken Institute Asia Summit 2015, David Bonderman, Josh Harris, Michael Milken, and Michael Kim discussed the global implications of China's market volatility and its structural transition from an export-driven to a consumer-led economy. The panelists, representing approximately $475 billion in assets, warned of tail risks associated with China's potential hard landing while identifying significant investment opportunities in Asia's aging demographics, healthcare sector, and financial technology gaps. Their consensus forecasted a prolonged low-interest-rate environment and emphasized that successful capital allocation requires deep localization and navigating the region's unique cultural and transparency challenges.
- Milken Institute1h 40m
Asia Summit 2015 - AIIB and the Evolving Multilateral Lending Landscape
Mike Milken, Lee Kuan Yew, Jin Li-chun, Tommy Koh, Jin Tong, Tadashi Maeda, Clive Kerner, Elena Okorochinko
At a Milken Institute discussion, AIIB President-designate Jin Li-chun outlined the bank's lean, clean, and green operational framework designed to complement existing multilateral development banks in addressing a global infrastructure financing gap of $2 trillion annually. With 57 provisional founding members approved and a target to operationalize by year-end, the institution plans to leverage a 2.5 gearing ratio to reach $250 billion in lending capacity while offering flexible financing stages to bridge the $8 trillion Asian infrastructure demand projected for 2030. Although major economies like the United States and Japan remain cautious, stakeholders including rating agencies and the IFC view the AIIB as a strategic partner capable of enhancing credit quality and mobilizing private capital for sustainable development.
- Milken Institute1h 42m
Asia Summit 2015 - Asias Future: Perspectives on Prospects and Challenges
Wing, Kirk Wager, Mike Milken, Cesar, Purisima, Kevin Sneader, Jing Ulrich, Tim Cofer, Achal Agarwal, Sam Fisher, Chris Wei
This event highlighted the United States' deepening strategic commitment to Southeast Asia, underpinned by a $220 billion cumulative investment in top ASEAN markets and projected to support a middle class growing from 525 million to 1.2 billion people by 2030. Key speakers detailed Indonesia's aggressive fiscal shifts, including a $32 billion subsidy cut and $22 billion infrastructure allocation, alongside the Philippines' demographic-driven growth fueled by its young, English-speaking workforce and expanding manufacturing sectors. Despite short-term currency volatility, the consensus among global corporations and government officials affirmed that Asia's unique blend of urbanization, digital innovation, and rising consumption will anchor the region as the primary engine of global economic expansion.
- Milken Institute55 min
Asia Summit 2015 - A World in Turmoil: Finding Opportunities Amid Volatility (II)
Clinda Amin, Mike Milken, Scott Minard, Piyush Gupta
The Milken Institute Asia Summit in Singapore convened 400 global leaders to analyze Asian economic resilience, highlighting China's robust foreign exchange reserves and structural realignment despite short-term market volatility. Panelists identified Africa's demographic dividend, Arctic shipping routes, and capital market inefficiencies as critical future growth engines while debating the timing of US Federal Reserve rate hikes. The event concluded by emphasizing the necessity of developing mature financial markets and socio-cultural ecosystems for innovation to address global shifts where the Asian economy is projected to exceed 50% of global output.
- Milken Institute1h 1m
Asia Summit 2015 - Treasure Hunters: Finding Value in Today's Market
Tom Finke, Paul Horvath, Rob Petty, Takumi Shibata, Hans Paul Birkner, Mike Milken, Chris Langer, Stefan Kostjusko
Four institutional managers from Babson, Orchid, Clearwater, and Nikkei Asset Management convened to argue for long-term value generation through high-yield credit and private lending amidst current market volatility and geopolitical uncertainty. The panel identified specific structural opportunities, including a $4 trillion regulatory capital gap for global banks, a $35 trillion Asian credit market, and the need for concentrated, high-conviction portfolios over traditional asset allocations. By prioritizing top-of-capital structures in non-bank lending and leveraging bank disintermediation strategies, the experts projected mid-teens returns while dismissing the existence of a prevailing high-yield credit bubble.
- Milken Institute1h 12m
Accelerating Medical Research: The Bipartisan Quest for Cures
Margaret Anderson, Bob Hugin, Francis Collins, Mike Milken, Sara Radcliffe, Joe Barton
Hosted by Faster Cures, the 18th Global Conference convened over 160 sessions to address the critical intersection of biomedical innovation and economic stability, featuring strategic insights from Bob Hugin, Mike Milken, and Francis Collins regarding the shrinking purchasing power of NIH funding and China's aggressive bioscience investments. Speakers highlighted the urgent need to revise legislative frameworks, such as the bipartisan 21st Century Cures initiative and dynamic scoring practices, to counter a 23% decline in federal research support that threatens U.S. leadership against global competitors. The event concluded with a unified call to action for sustained advocacy and targeted funding for young scientists to secure future breakthroughs in precision medicine and drug repurposing.
- Milken Institute1h 4m
Precision Medicine: Accelerating Treatments From Potential to Reality
Mike Milken, Margaret Anderson, Pradeep Khosla, Brian Drucker, Betsy Nabel, Sam Hoggud
Distinguished experts including Pradeep Khosla, Brian Drucker, and Sam Hogg convened to discuss the transformation of medicine into a collaborative, data-driven field where precision and artificial intelligence have replaced traditional research silos. Despite significant breakthroughs like the rapid development of Gleevec, panelists warned that underfunding, a lack of trained physician-scientists, and intense global competition threaten U.S. leadership in the bioscience sector. The group concluded that realizing this "golden age of medicine" requires an urgent Apollo-style initiative, multi-sector co-investment, and a cultural shift toward patient partnerships to secure global health preeminence.
- Milken Institute57 min
Around the World in 60 Minutes: Creating Global Prosperity
Mike Milken, Tony, Strive, Nouriel, Kathy
The 18th annual Milken Institute Global Conference convened 4,000 attendees and global leaders including Tony Blair and Nouriel Roubini to address the dual challenges of global job creation and economic resilience. Key outcomes included the formation of a task force targeting one billion new jobs and strategic imperatives emphasizing migration liberalization, human capital investment, and health infrastructure to counter automation and demographic shifts. By shifting focus from aid to trade and advocating for lifelong learning, the panel established a framework for future prosperity centered on open governance and innovation.